PHARMACYCLICS INC Operating Margin
- Operating margin · 12 months: Value 13.23%; Formula and calculation Operating income / revenue. Period ending 2015-03-31..
Operating margin
Overview →Financial period ending 2015-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 13.23% | Operating income / revenue. Period ending 2015-03-31. $107.94M ÷ $816.12M × 100 ≈ 13.23% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 107.94M USD | Operating Income (Loss) |
| Revenue | 816.12M USD | |
| Cost of products and services | (m) | |
| Research and development | 186.54M USD | Research and Development Expense |
| Selling, general and administration | 182.75M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2015-03-31 | $107.94M | $816.12M | (m) | $186.54M | $182.75M | 13.23% |
| 2014-12-31 | $122.38M | $729.73M | (m) | $172.46M | $167.96M | 16.77% |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $169.11M | $376.70M | (m) | $84.64M | $88.30M | 44.89% |
| 2013-12-31 | $97.92M | $260.17M | (m) | $85.13M | $73.61M | 37.64% |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $49.60M | $165.63M | (m) | (m) | (m) | 29.95% |
| 2012-12-31 | $84.61M | $164.71M | (m) | (m) | (m) | 51.37% |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $27.05M | $81.39M | (m) | (m) | (m) | 33.23% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $-35.37M | $8.23M | (m) | (m) | (m) | -429.66% |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | $-15.61M | $9.31M | (m) | (m) | (m) | -167.74% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.